Lhasa Limited shared knowledge shared progress



6 September 2017



Webinar - AI/PDE Data Sharing: Streamlining the risk assessment workflow


AIPDE logo

Initiated in 2017 and using Lhasa’s Vitic Nexus platform, the AI/PDE project brings together top pharmaceutical organisations to share and harmonise Acceptable Intake (AI) and Permitted Daily Exposure (PDE) data.

The calculation of AIs/PDEs is required in regulatory submission under various guidelines including ICH M7 and ICH Q3A/B/C. This process is often time consuming, with the potential for duplicate or inconsistent assessments across pharmaceutical organisations worldwide.

This webinar describes how AI/PDE data sharing can enhance the safety of drug substances and streamline the risk assessment workflow by allowing organisations to rapidly access a harmonised and agreed-upon series of AIs/PDEs for commonly used reagents and solvents.


Presented by Dr Will Drewe, Business Development Manager, and David Wilkinson, Senior Scientist. 

Please see below for a recording. 

  • Headline Event (shown first above featured)

  • Featured Event

Related Publications

Back to events

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.